The article offers news briefs related to medicine in the U.S. A new bill which aimed to outline a pathway for the Food and Drug Administration approval on follow-on protein products was passed by the U.S. Senate panel. Major pharmaceutical companies emphasize their continuous investment on the emerging RNAi technologies. The U.S. National Cancer Institute has cancelled the disease prevention study on women at high risk of breast cancer.
Processing Request
No Comments.